Pharmacist Education | Hypertension Podcast 1 credit hour

Many patients continue to have blood pressure above goal despite treatment, creating opportunities for pharmacy teams to support medication use, monitoring, and follow-up. This course reviews the role of recently approved baxdrostat in hypertension management, as well as emerging evidence on the tolerability of antihypertensive therapies and combinations. You will be better prepared to support patients as antihypertensive therapy is intensified.

Available in Subscription

This course is included in the following subscription:

Pharmacist CE Subscription

Pharmacist CE Subscription

Renewed Annually
$99.00 / year

Learning Objectives

Upon successful completion of this course, learners should be able to:
1. Describe the role of baxdrostat in hypertension management when blood pressure remains above goal despite treatment.
2. Explain practical considerations for medication tolerability, monitoring, and patient education when antihypertensive therapy is intensified.

Faculty

Rachel Maynard, PharmD

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Eric MacLaughlin, Pharm.D., BCPS

Disclosures:

Eric MacLaughlin is a Consultant for AstraZeneca and CMEVacations. All relevant financial relationships have been mitigated.

Course Details